Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments – Biologics License Application (BLA) 125827, from Replimune, Inc. for vusolimogene oderparepvec.

Documents

Comments

130

Key Dates

Comment Period OpensJul 8, 2026

Comment Period ClosesJul 30, 2026

Type	Title	Posted	Comments	Status
Notice	Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—Biologics License Application (BLA) 125827, From Replimune, Inc. for Vusolimogene Oderparepvec FR Doc: 2026-15017	Jul 24, 2026

Total Comments

130

CBER

2026-400

Cellular, Tissue,

and Gene Therapies Advisory Committee

Notice of Meeting

Establishment of a Public Docket

Request for Comments

Biologics License Application (BLA) 125827